Virbac AH, Inc. is voluntarily recalling approximately 10,098 bottles of Clintabs (clindamycin hydrochloride) tablets because they were distributed without necessary product labeling. These prescription antibiotic tablets are intended for use in dogs only and are sold in 25 mg, 75 mg, and 150 mg strengths. Missing labels can lead to the improper administration of medication or the use of the drug for the wrong animal, which may result in ineffective treatment or adverse reactions. Consumers should check their pet's medication immediately to see if it is part of this recall.
Missing product labels mean critical dosing instructions, safety warnings, and usage information are unavailable, which could lead to medication errors or pet injury. While this is a low-risk recall, the absence of labeling prevents the safe and effective use of the prescription drug.
Contact healthcare provider and return product.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response